loading
前日終値:
$35.18
開ける:
$34.93
24時間の取引高:
343.87K
Relative Volume:
0.34
時価総額:
$3.36B
収益:
$4.72M
当期純損益:
$-277.91M
株価収益率:
-9.6005
EPS:
-3.73
ネットキャッシュフロー:
$-203.56M
1週間 パフォーマンス:
+0.65%
1か月 パフォーマンス:
+18.68%
6か月 パフォーマンス:
+1.83%
1年 パフォーマンス:
-29.21%
1日の値動き範囲:
Value
$34.52
$35.96
1週間の範囲:
Value
$33.27
$36.31
52週間の値動き範囲:
Value
$24.10
$62.53

Crinetics Pharmaceuticals Inc Stock (CRNX) Company Profile

Name
名前
Crinetics Pharmaceuticals Inc
Name
セクター
Healthcare (1151)
Name
電話
858-450-6464
Name
住所
6055 LUSK BLVD., SAN DIEGO, CA
Name
職員
437
Name
Twitter
@Crinetics
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
CRNX's Discussions on Twitter

CRNX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CRNX
Crinetics Pharmaceuticals Inc
35.73 3.38B 4.72M -277.91M -203.56M -3.73
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
378.45 97.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
448.67 59.56B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.39 60.19B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
703.81 44.94B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
326.03 36.14B 3.81B -644.79M -669.77M -6.24

Crinetics Pharmaceuticals Inc Stock (CRNX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-10 開始されました Goldman Neutral
2025-03-25 開始されました Stifel Buy
2025-02-11 開始されました TD Cowen Buy
2025-02-04 開始されました Wolfe Research Peer Perform
2025-01-22 アップグレード Jefferies Hold → Buy
2024-03-06 開始されました Citigroup Buy
2024-01-16 開始されました Morgan Stanley Overweight
2023-12-21 開始されました Jefferies Hold
2023-11-20 再開されました JP Morgan Overweight
2023-10-24 再開されました Cantor Fitzgerald Overweight
2023-08-31 開始されました Oppenheimer Outperform
2023-04-24 開始されました Piper Sandler Overweight
2023-03-30 開始されました Robert W. Baird Outperform
2021-11-30 開始されました JMP Securities Mkt Outperform
2021-11-23 開始されました Evercore ISI Outperform
2021-06-18 アップグレード JP Morgan Neutral → Overweight
2019-12-23 開始されました ROTH Capital Buy
2019-02-14 開始されました H.C. Wainwright Buy
2018-08-13 開始されました JP Morgan Neutral
2018-08-13 開始されました Leerink Partners Outperform
2018-08-13 開始されました Piper Jaffray Overweight
すべてを表示

Crinetics Pharmaceuticals Inc (CRNX) 最新ニュース

pulisher
Sep 24, 2025

JP Morgan Lowers Price Target for CRNX While Maintaining Overwei - GuruFocus

Sep 24, 2025
pulisher
Sep 24, 2025

JPMorgan Chase & Co. Cuts Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $52.00 - MarketBeat

Sep 24, 2025
pulisher
Sep 23, 2025

CRNX FDA Catalyst Alert: Could Paltusotine Decision Reshape Endocrine Drug Market? - Nasdaq

Sep 23, 2025
pulisher
Sep 22, 2025

Crinetics Pharmaceuticals (NASDAQ:CRNX) Trading Down 4.7%Time to Sell? - MarketBeat

Sep 22, 2025
pulisher
Sep 21, 2025

Crinetics Pharmaceuticals, Inc. $CRNX Shares Purchased by Intech Investment Management LLC - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Crinetics Pharmaceuticals, Inc. $CRNX Stock Holdings Trimmed by Voya Investment Management LLC - MarketBeat

Sep 20, 2025
pulisher
Sep 19, 2025

Momentum divergence signals in Crinetics Pharmaceuticals Inc. chartWeekly Investment Report & Safe Capital Growth Tips - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Rhumbline Advisers Increases Position in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Short interest data insights for Crinetics Pharmaceuticals Inc.2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

CEO Change: What’s the beta of Crinetics Pharmaceuticals Inc. stockLayoff News & Safe Capital Investment Plans - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Visual analytics tools that track Crinetics Pharmaceuticals Inc. performanceStop Loss & Weekly Top Stock Performers List - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

What Fibonacci levels say about Crinetics Pharmaceuticals Inc. reboundMarket Sentiment Report & Low Risk Profit Maximizing Plans - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Marquis Who's Who Honors Tiffany P. Quock, PhD, MS, for Expertise in the Pharmaceutical Industry - 24-7 Press Release Newswire

Sep 19, 2025
pulisher
Sep 19, 2025

Using fundamentals and technicals on Crinetics Pharmaceuticals Inc.Inflation Watch & High Return Trade Guides - newser.com

Sep 19, 2025
pulisher
Sep 18, 2025

What’s next for Crinetics Pharmaceuticals Inc. stock priceShort Setup & Capital Efficiency Focused Strategies - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

Those who invested in Crinetics Pharmaceuticals (NASDAQ:CRNX) five years ago are up 151% - Yahoo Finance

Sep 18, 2025
pulisher
Sep 18, 2025

Setup Watch: Can Crinetics Pharmaceuticals Inc be recession proofJuly 2025 Outlook & AI Forecasted Stock Moves - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Aug Analyst Calls: What is Crinetics Pharmaceuticals Inc.’s TAM (Total Addressable Market)2025 Institutional Moves & Low Risk High Reward Ideas - خودرو بانک

Sep 18, 2025
pulisher
Sep 17, 2025

Treasury Yields: What are NXGL’s technical support levelsInflation Watch & Real-Time Stock Movement Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Short Covering: Is Crinetics Pharmaceuticals Inc. likely to announce a buybackMarket Activity Summary & High Conviction Buy Zone Alerts - khodrobank.com

Sep 17, 2025
pulisher
Sep 17, 2025

Rally Mode: What is the dividend yield of Crinetics Pharmaceuticals Inc2025 Momentum Check & Advanced Technical Analysis Signals - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Is Crinetics Pharmaceuticals Inc. meeting your algorithmic filter criteria2025 Technical Overview & Weekly High Return Forecasts - newser.com

Sep 17, 2025
pulisher
Sep 17, 2025

Published on: 2025-09-17 14:31:30 - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

Chart Watch: What is the PEG ratio of Crinetics Pharmaceuticals IncQuarterly Profit Summary & Expert Curated Trade Setups - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Sell Signal: Should value investors consider Crinetics Pharmaceuticals IncPortfolio Performance Report & Daily Technical Stock Forecast Reports - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Crinetics Pharmaceuticals Inc. stock trendline breakdownExit Point & Smart Investment Allocation Insights - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

Published on: 2025-09-16 16:37:44 - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

Investment Report: What is the dividend yield of Crinetics Pharmaceuticals IncShort Setup & Reliable Volume Spike Trade Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Performance Recap: Is Crinetics Pharmaceuticals Inc a stock for growth or value investorsTrade Analysis Summary & Free Reliable Trade Execution Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Death Cross: What is Crinetics Pharmaceuticals Inc.’s TAM (Total Addressable Market)Market Growth Review & Real-Time Chart Breakout Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Crinetics Pharmaceuticals (NASDAQ:CRNX) Stock Price Down 2.7%Time to Sell? - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Using portfolio simulators with Crinetics Pharmaceuticals Inc. included2025 Market Trends & Community Consensus Stock Picks - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

Market Overview: Can SCE Trust VI Preferred Security continue delivering strong returnsLayoff News & Capital Efficiency Focused Strategies - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Guidance Update: Can Crinetics Pharmaceuticals Inc. outperform under higher oil pricesTrade Volume Summary & Weekly Sector Rotation Insights - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Volume Report: Is Crinetics Pharmaceuticals Inc. stock a good dividend stock2025 Pullback Review & Long-Term Investment Growth Plans - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Bearish Setup: Is Crinetics Pharmaceuticals Inc stock a top performer YTD2025 Market Sentiment & Advanced Technical Signal Analysis - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Exome Asset Management LLC Purchases Shares of 51,295 Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat

Sep 15, 2025
pulisher
Sep 14, 2025

Are Investors Undervaluing Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) By 28%? - 富途牛牛

Sep 14, 2025
pulisher
Sep 13, 2025

9 of the Fastest-Growing Biotech Stocks Under $10 Billion - TIKR.com

Sep 13, 2025
pulisher
Sep 12, 2025

Dupont Capital Management Corp Sells 561 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - 富途牛牛

Sep 12, 2025
pulisher
Sep 12, 2025

Parkman Healthcare Partners LLC Purchases 12,807 Shares of Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat

Sep 12, 2025
pulisher
Sep 10, 2025

Crinetics Pharmaceuticals Announces September 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Sep 10, 2025
pulisher
Sep 10, 2025

62,475 Stock Options at $35/Share: Crinetics Pharmaceuticals Awards Inducement Grants to New Hires - Stock Titan

Sep 10, 2025
pulisher
Sep 09, 2025

Cormorant Asset Management LP Has $20.12 Million Stock Holdings in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat

Sep 09, 2025

Crinetics Pharmaceuticals Inc (CRNX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Crinetics Pharmaceuticals Inc (CRNX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Pizzuti Dana
Chief Med and Dev Officer
Sep 02 '25
Sale
32.10
5,000
160,500
96,270
$35.02
price down icon 1.82%
$81.92
price down icon 2.65%
$28.89
price down icon 1.87%
$98.02
price down icon 1.75%
$135.71
price down icon 3.64%
biotechnology ONC
$328.11
price down icon 0.38%
大文字化:     |  ボリューム (24 時間):